Montag & Caldwell LLC Reduces Stake in Ulta Beauty Inc (NASDAQ:ULTA)

Share on StockTwits

Montag & Caldwell LLC lessened its position in Ulta Beauty Inc (NASDAQ:ULTA) by 3.3% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 193,419 shares of the specialty retailer’s stock after selling 6,686 shares during the period. Ulta Beauty comprises 3.5% of Montag & Caldwell LLC’s portfolio, making the stock its 10th largest holding. Montag & Caldwell LLC’s holdings in Ulta Beauty were worth $67,095,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently modified their holdings of ULTA. Comerica Securities Inc. increased its position in shares of Ulta Beauty by 19.9% in the fourth quarter. Comerica Securities Inc. now owns 1,381 shares of the specialty retailer’s stock valued at $338,000 after acquiring an additional 229 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Ulta Beauty by 3.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 302,664 shares of the specialty retailer’s stock valued at $74,098,000 after acquiring an additional 10,616 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Ulta Beauty by 8.0% in the fourth quarter. Geode Capital Management LLC now owns 838,542 shares of the specialty retailer’s stock valued at $204,993,000 after acquiring an additional 62,309 shares during the last quarter. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Ulta Beauty in the first quarter valued at about $263,000. Finally, Altman Advisors Inc. increased its position in shares of Ulta Beauty by 1.8% in the first quarter. Altman Advisors Inc. now owns 5,542 shares of the specialty retailer’s stock valued at $1,933,000 after acquiring an additional 96 shares during the last quarter. Hedge funds and other institutional investors own 88.67% of the company’s stock.

In other news, Director Catherine Ann Halligan sold 400 shares of the company’s stock in a transaction that occurred on Friday, June 7th. The stock was sold at an average price of $343.02, for a total value of $137,208.00. Following the transaction, the director now owns 2,811 shares of the company’s stock, valued at $964,229.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Sally E. Blount sold 315 shares of the company’s stock in a transaction that occurred on Friday, June 21st. The shares were sold at an average price of $359.28, for a total value of $113,173.20. Following the completion of the transaction, the director now directly owns 989 shares in the company, valued at approximately $355,327.92. The disclosure for this sale can be found here. Insiders sold 2,715 shares of company stock worth $958,441 in the last ninety days. 4.20% of the stock is owned by company insiders.

NASDAQ ULTA traded up $1.09 during trading on Thursday, reaching $322.09. 572,811 shares of the company’s stock were exchanged, compared to its average volume of 669,312. The firm’s 50 day simple moving average is $348.03. The firm has a market capitalization of $19.67 billion, a PE ratio of 29.69, a P/E/G ratio of 1.43 and a beta of 0.96. The company has a quick ratio of 0.74, a current ratio of 1.93 and a debt-to-equity ratio of 0.85. Ulta Beauty Inc has a fifty-two week low of $224.43 and a fifty-two week high of $368.83.

Ulta Beauty (NASDAQ:ULTA) last posted its earnings results on Thursday, May 30th. The specialty retailer reported $3.08 EPS for the quarter, beating the consensus estimate of $3.06 by $0.02. Ulta Beauty had a return on equity of 36.48% and a net margin of 9.92%. The company had revenue of $1.74 billion for the quarter, compared to the consensus estimate of $1.74 billion. During the same quarter in the prior year, the business earned $2.70 earnings per share. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. On average, analysts forecast that Ulta Beauty Inc will post 12.77 earnings per share for the current year.

A number of analysts recently issued reports on ULTA shares. Deutsche Bank lifted their target price on Ulta Beauty from $300.00 to $315.00 and gave the company a “hold” rating in a research report on Monday, June 3rd. Robert W. Baird reissued an “outperform” rating and set a $395.00 price target (up previously from $365.00) on shares of Ulta Beauty in a research report on Thursday, April 18th. Zacks Investment Research raised Ulta Beauty from a “hold” rating to a “buy” rating and set a $384.00 price target on the stock in a research report on Monday, May 20th. UBS Group boosted their price target on Ulta Beauty from $370.00 to $390.00 and gave the stock a “top pick” rating in a research report on Thursday, July 25th. Finally, ValuEngine downgraded Ulta Beauty from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Seven research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $353.39.

Ulta Beauty Profile

Ulta Beauty, Inc operates as a beauty retailer in the United States. The company's stores offer cosmetics, fragrances, skincare and haircare products, bath and body products, and salon styling tools; salon services, including hair, skin, makeup, and brow services; and others, including nail products and accessories.

Featured Article: Dollar Cost Averaging

Want to see what other hedge funds are holding ULTA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ulta Beauty Inc (NASDAQ:ULTA).

Institutional Ownership by Quarter for Ulta Beauty (NASDAQ:ULTA)

Receive News & Ratings for Ulta Beauty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ulta Beauty and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.